Best online GLP-1 providers
The best provider is the one whose exact medication, price basis, clinical process, and pharmacy path fit the decision you need to make.
Read the guide2026 GLP-1 guides: semaglutide from $99/mo
Continuing compounded semaglutide in this catalog runs from $89 to $299 a month, and compounded tirzepatide from $129 to $399 a month, with checks through 22 October 2026. Compare the cheapest GLP-1 prices · Wegovy pill versus injection · Foundayo cost in 2026 · Compounded tirzepatide prices.
Latest
- Compounded tirzepatide cost in 2026: $129 to $399 · 12 min read
- Class II compounded GLP-1 recalls, Oct 2026 · 12 min read
- Compounded semaglutide cost in 2026: $89 to $299 · 10 min read
GLP-1 across products
Class II compounded GLP-1 recalls, Oct 2026
Two compounding firms have ongoing Class II recalls in FDA's 14 October 2026 enforcement data. The records list lot codes. They do not name a telehealth brand.
Read the guide
Compounded GLP-1 in 2026: $89 to $299/mo
The misconception: a low price means a diluted or fake product and a high price means a better pharmacy. Prices differ because there is no list price and each program bundles different things.
Read the guideCompounded GLP-1s: Pharmacy, Formulation, FDA Status, and Questions to Ask
Compounded semaglutide and tirzepatide are not FDA-approved products, and FDA does not pre-review them for safety, effectiveness, or quality. Verify the prescriber, pharmacy, active ingredient, formulation, and current regulatory context, and do not use vial or unit conversions from a web article.
Read the guideDoes the price include the medication? How to read it
The misconception: the advertised monthly price is what you pay. Often it is a membership fee, and the medication is a second charge set after the prescriber picks a dose.
Read the guideFDA Empower Pharmacy warning letter, Sept 2026
Warning letter WL 738238, dated September 18, 2026, is addressed to Empower Pharmacy in Houston. FDA says three named compounded products appear to be essentially copies of approved semaglutide and tirzepatide drugs. Order counts are redacted.
Read the guide
Foundayo cost in 2026: price by dose, savings card, and Medicare
Lilly's Foundayo self-pay price is $149 to $349 for a 30-day supply, depending on dose and refill timing. Savings cards, TrumpRx, and the Medicare Bridge are separate routes.
Read the guideGLP-1 alternatives for weight management
An alternative is useful only when it solves the reason the original option does not fit, such as indication, side effects, cost, access, route, or preference.
Read the guide
GLP-1 Blood Work and Monitoring: What Your Clinician May Track and Why
There is no universal GLP-1 lab panel. Monitoring follows the exact product, diabetes status, symptoms, other medicines, kidney-risk context, nutrition, and treatment goals.
Read the guideGLP-1 buy now, pay later, compared
Eleven commission-earning pages were opened on 21 October 2026. Two name Klarna or Afterpay as a checkout option. Four state HSA or FSA and no split-pay brand. Four state neither.
Read the guideGLP-1 cancel: full refund if not prescribed
The misconception: I can cancel and get my money back. Most programs refund before the prescription review and almost never after the pharmacy has the order; the window in between is where the terms differ.
Read the guideGLP-1 cash prices after Dec 31, 2026: $199 ends
The dated cash offers that end on December 31, 2026 are the Wegovy and Ozempic $199 starter fills and the Foundayo 2.5 mg and 5.5 mg temporary prices. Zepbound's $449 price is a 45-day refill rule.
Read the guideGLP-1 Eligibility and Contraindications: What a Clinician Reviews Before Treatment
Eligibility is product- and indication-specific. A clinician reviews health history, medicines, pregnancy plans, labeled contraindications, and risks that make one option more or less suitable.
Read the guideGLP-1 insurance coverage and access
Coverage depends on the exact drug, indication, plan, and approval pathway. This guide shows how to get a usable answer before paying.
Read the guideIs compounded semaglutide or tirzepatide still legal?
Two opposite myths: it is banned, and nothing changed. Neither is right. Compounding continues under narrow patient-specific rules while FDA moves to close the 503B route.
Read the guideMounjaro from $1,399/mo vs Wegovy from $349
These products sit in different labeled contexts. A direct molecule comparison is not the same as a direct product verdict.
Read the guide
Mounjaro vs. Ozempic: FDA Uses, Trial Context, Safety, and Telehealth Costs
The same weekly cadence does not make these diabetes medicines interchangeable. Start with the label, then compare evidence and total cost.
Read the guide
Ozempic vs. Zepbound: Different FDA Uses, Evidence Context, and Telehealth Costs
These products use different active ingredients and have different labeled uses. A near match in drug class is not a substitution rule.
Read the guide
Semaglutide vs Tirzepatide: Evidence, Safety, Approved Uses, and Questions for Your Clinician
Semaglutide is a GLP-1 receptor agonist and tirzepatide is a dual GIP/GLP-1 receptor agonist, but a treatment decision is not settled by mechanism or a headline result. The direct comparison cited here is in type 2 diabetes; obesity trials have different populations and designs.
Read the guideSwitching GLP-1 telehealth providers: what moves with you
The misconception: my prescription is mine and moves with me. A compounded prescription stays with the old program's pharmacy; a brand prescription can go to NovoCare or LillyDirect from any prescriber.
Read the guideWegovy vs. Zepbound: What the Head-to-Head Trial, Labels, and Costs Show
The direct obesity trial is useful. It is not a forecast, a dose-conversion table, or a universal winner.
Read the guideWhat Happens When You Stop a GLP-1? What Withdrawal Trials Show About Weight Regain
Semaglutide and tirzepatide withdrawal studies found substantial average regain after treatment stopped, while continued treatment better maintained loss in the studied groups. The personal plan should be clinician-led.
Read the guideWhy GLP-1 price goes up after month 1: $199 then $349
The misconception: the pharmacy raised its price. Almost always, month one was a promotion, a starting dose, or a prepaid rate, and month two is the price that was there all along.
Read the guideSemaglutide: Wegovy, Ozempic, compounded
Best online semaglutide: compare care and plan terms
Wegovy, Ozempic, and compounded semaglutide are different products. Compare a medication-included continuing price from a commission-earning provider, and leave an unnamed winner unnamed.
Read the guideCompounded semaglutide cost in 2026: $89 to $299
Thirteen providers publish a calendar-month compounded semaglutide price. The range is $89 to $299, and the median is $165. yourEra is $89, checked 22 October 2026.
Read the guideCompounded Semaglutide vs Wegovy: What Is Actually Different
Same active ingredient name, different product. Wegovy is FDA-approved and sold by Novo Nordisk. Compounded semaglutide is pharmacy-made, unapproved, and sold through telehealth.
Read the guide
Foundayo vs Wegovy pill: both $149 (Oct 2026)
Both are once-daily oral GLP-1 medicines. Foundayo has no fasting rule and a $649 list price. The Wegovy tablet is a morning fasting dose with a $1,349.02 list price. Their obesity trials were separate.
Read the guideHow Much Does Wegovy Cost in 2026: List Price, NovoCare, Insurance, Telehealth
Wegovy lists at $1,349.02 per package. Most people pay far less through the NovoCare self-pay price, a commercial savings card, or the Medicare GLP-1 Bridge. Telehealth adds a consultation, not a discount.
Read the guideHow Semaglutide Works for Weight Loss: GLP-1, Appetite, Digestion, and the Evidence
Semaglutide is a GLP-1 receptor agonist. Its labeled pharmacology includes appetite and gastric-emptying effects, while weight-management evidence comes from defined trials with lifestyle intervention rather than a promise of a specific result.
Read the guideOral vs Injectable Semaglutide: Approved Uses, Evidence, and Questions for Your Clinician
Oral and injectable semaglutide should not be compared dose-for-dose. Current labels describe different products, indications, formulations, and administration requirements, and OASIS 1 is trial evidence rather than an automatic substitute for an approved injectable regimen.
Read the guideOzempic 2026: $199 then $349, $499 at 2 mg
Novo Nordisk sets the Ozempic price and sells it directly. The dose you are on, the insurance you hold, and the calendar all move the number, and one of them moves it on January 1, 2027.
Read the guideOzempic vs Compounded Semaglutide: What Is Actually Different
Ozempic is Novo Nordisk's FDA-approved semaglutide for type 2 diabetes. Compounded semaglutide is an unapproved pharmacy product sold for weight loss. Neither is Wegovy.
Read the guideOzempic vs Wegovy in 2026: different FDA uses
Ozempic is labeled for type 2 diabetes. Wegovy is labeled for chronic weight management. Checked 2 October 2026, Sesame Care lists Wegovy at $349 a month after two months at $199, plus $99 a month for care.
Read the guideSemaglutide Side Effects: Common Symptoms, Serious Warnings, and When to Get Help
Semaglutide can cause common GI effects. Severe symptoms, dehydration, eye changes in diabetes, or allergic symptoms need clinical assessment.
Read the guideSemaglutide Weight-Loss Timeline: What Clinical Trials Show Over Time
Semaglutide outcomes developed over months in STEP 1. The study is evidence, not a personal calendar.
Read the guideWegovy pill $149–$299 vs injection $199 then $349
Both are FDA-approved Wegovy from Novo Nordisk. The pill is a daily 25 mg tablet taken fasting; the injection is a weekly 2.4 mg pen. Labels, prices, and storage differ.
Read the guideWegovy: NovoCare vs telehealth price, explained
The misconception: telehealth companies sell Wegovy cheaper. They prescribe the same Novo Nordisk product; the drug price is Novo's, and the telehealth fee sits on top of it.
Read the guideTirzepatide: Zepbound, Mounjaro, compounded
Best Zepbound providers compared in 2026
The August 2026 Zepbound label identifies the brand. Commission-earning providers with a published medication-included Zepbound price are listed below. Mounjaro and compounded tirzepatide are different products.
Read the guideCompounded tirzepatide cost in 2026: $129 to $399
Thirteen commission-earning providers have a calendar-month compounded tirzepatide price. The range is $129 to $399, and the median is $299. Prepaid and 4-week bills are labeled apart.
Read the guideCompounded tirzepatide plans, Oct 2026: $119 to $269
Verified multi-month compounded tirzepatide plans run from $119 a month on SnagRX's 12-month column to $269 a month on Shed's 6-month column. Upfront totals are quoted only when the page or the matching catalog row states them.
Read the guideHow Much Does Zepbound Cost in 2026: List Price, LillyDirect Vials, Insurance, and Telehealth
Zepbound lists at $499 to $1,086.37 per fill. Self-pay vials and the KwikPen run $299 to $699 a month by dose, the savings card brings covered patients to $25, and the Medicare Bridge charges $50 for the KwikPen. Telehealth adds a consultation, not a discount.
Read the guideHow Tirzepatide Works for Weight Loss: Dual GIP/GLP-1 Action and What Trials Show
Tirzepatide is a dual GIP and GLP-1 receptor agonist. Mechanism is useful context, but treatment choice should rest on labeled indication, evidence, safety history, access, and shared decision-making.
Read the guideLillyDirect vs telehealth Zepbound: $299 to $449
The misconception: a telehealth program has its own Zepbound price. Lilly sells vials and KwikPens only through LillyDirect, so the telehealth price is Lilly's ladder plus a fee, and the 45-day refill rule applies either way.
Read the guideMounjaro vs. Zepbound: Same Active Ingredient, Different FDA Uses and Costs
The same active ingredient does not make two branded products a self-service switch.
Read the guide
Oral vs Injectable Tirzepatide: FDA Status, Formulation Questions, and What to Verify
The FDA labels cited here describe tirzepatide as an injection. Any oral tirzepatide offer needs a current verification of formulation and FDA status; do not imply that an oral compounded product has the same evidence, quality review, or dose equivalence as an approved injection.
Read the guideTirzepatide 2026: compounded from $149/mo
Zepbound is Eli Lilly's FDA-approved tirzepatide. Compounded tirzepatide is pharmacy-made and unapproved. The ingredient name is where the similarity ends.
Read the guideTirzepatide Side Effects: Common Symptoms, Serious Warnings, and When to Call Your Clinician
GI symptoms are common. Severe or persistent symptoms need clinical attention, not self-directed medication changes.
Read the guideTirzepatide Weight-Loss Timeline: What Clinical Trials Show Over Time
Tirzepatide results in trials accumulated over months. A timeline should teach study context, not promise a weekly result.
Read the guideYour First Week on Tirzepatide: What to Expect, What to Track, and When to Contact Your Clinician
The first week is for adjustment and safety monitoring, not a verdict on long-term response.
Read the guideZepbound vials vs pens: $299 at 2.5 mg (Sep 10)
Every Zepbound presentation is FDA-approved tirzepatide from Lilly. Vials need a syringe and cost less on self-pay; pens are fixed-dose devices with savings-card and Medicare pathways.
Read the guideNAD+
How NAD+ Injections Work: The Biology, Human Studies, and Limits of the Evidence
NAD+ biology is real. It does not itself prove a compounded injection improves a clinical outcome.
Read the guideNAD+ injection cost in 2026: $93 to $249 a month
Eleven commission-earning providers publish a calendar-month NAD+ injection price. The range is $93 to $249, and the median is $159. A 4-week bill and a prepaid total are different charges.
Read the guideNAD+ Injection Side Effects and Safety: What the Human Evidence and FDA Say
NAD+ biology does not prove safety or effectiveness for a compounded wellness injection.
Read the guide
NAD+ Injections vs. IV, Nasal Spray, and Oral NAD: What Is and Is Not Comparable
A route label does not establish that products are equivalent, safer, or more effective.
Read the guideNAD+ Injections: What Human Studies Show and the Evidence Gaps That Remain
The human evidence is limited, heterogeneous, and not a general wellness verdict.
Read the guideWhat to Expect From NAD+ Telehealth: Intake, Pharmacy Questions, Costs, and Evidence Limits
The useful expectation is a transparent process, not a guaranteed prescription or wellness result.
Read the guideSermorelin, glutathione, and other peptides
GHK-Cu injections: human evidence, FDA safety concerns, and what is not established
Topical and laboratory findings do not establish injectable GHK-Cu safety or benefit in humans.
Read the guide
Glutathione injection side effects: FDA alerts, sterile-compounding risks, and when to seek care
The central safety question is product quality and acute reaction risk, not a wellness promise.
Read the guideGlutathione Injection vs Oral vs IV: What Is Actually Different
Injections and IV infusions are compounded sterile drugs. Oral glutathione is a dietary supplement. None is an FDA-approved glutathione drug, and each is bought and priced differently.
Read the guide
Glutathione injections: prices, evidence & 2026 recall
Compare published telehealth prices, evidence limits, and the exact scope of the August 2026 FDA-posted recall.
Read the guideGlutathione injections: what human studies show, and what they do not
Human IV studies exist in specific medical settings. They do not prove broad wellness, detox, or longevity benefits.
Read the guide
How Sermorelin Works and What Human Evidence Actually Shows
A biological mechanism is not a forecast of better sleep, recovery, body composition, or aging outcomes.
Read the guideSermorelin Blood Work and Monitoring: What Clinicians Evaluate and Why a Generic Lab List Is Not Enough
A generic lab checklist can create false confidence. Proper endocrine evaluation uses clinical context.
Read the guide
Sermorelin cost 2026, $99 to $216.18 a month
Eleven commission-earning providers publish a compounded sermorelin injection price. The continuing range is $99 to $216.18 a month, median $199. A prepaid or first-period figure on the same page is a different charge.
Read the guideSermorelin Results Timeline: What Evidence Supports, What It Does Not, and What to Ask
There is no evidence-based week-by-week wellness timeline for sermorelin.
Read the guideSermorelin Side Effects and Safety: What Human Evidence Can and Cannot Show
The evidence does not support a wellness safety promise. Historical pediatric evidence is not a shortcut to adult telehealth claims.
Read the guideSermorelin vs. Tesamorelin: FDA Status, Evidence, Safety, and What Is Not Comparable
Related is not interchangeable. Tesamorelin's current product label is not evidence for sermorelin wellness use.
Read the guide
Tesamorelin results timeline: what HIV lipodystrophy trials measured over weeks and months
Tesamorelin timelines come from HIV-associated lipodystrophy trials, not a universal body-composition promise.
Read the guideMenopause, HRT, and women's health
Menopause hormone therapy side effects and safety: what depends on the regimen
Hormone-therapy safety depends on the product, route, timing, duration, and medical history.
Read the guideMenopause telehealth HRT cost: consultation, labs, medication, and recurring fees
The price that matters is the full, dated cost structure, not a single monthly headline.
Read the guideMenopause telehealth labs: when blood tests help, when they do not, and what to ask
Most typical menopause diagnoses do not rest on one hormone panel. The useful question is what a test can change.
Read the guidePT-141 (bremelanotide): side effects, evidence, and who the FDA indication covers
Bremelanotide's FDA indication is narrow. It is not a general sexual-performance medication.
Read the guideTelehealth HRT eligibility and intake: what a safe menopause-care evaluation should cover
A clinical intake should assess fit and safety. It should not guarantee a prescription.
Read the guideThe first 90 days of menopause hormone therapy: follow-up, changes, and safety signals
The first 90 days are a monitoring period rather than a fixed transformation timeline.
Read the guideTRT and men's health
Enclomiphene vs. TRT: evidence, fertility, approval status, and questions for a clinician
Enclomiphene and testosterone replacement are not interchangeable, and their evidence and regulatory status differ.
Read the guideTelehealth TRT: eligibility, testing, costs, and how the process should work
Telehealth TRT should begin with a diagnosis and a monitoring plan, not a monthly-price checkout.
Read the guideTestosterone therapy side effects and safety: warnings, monitoring, and fertility considerations
Testosterone therapy has product-specific warnings and class-level safety questions. Fertility belongs in the first conversation.
Read the guideThe first 90 days of TRT: follow-up, monitoring, and what evidence cannot predict
The early TRT window is for clinical follow-up, not a guaranteed transformation schedule.
Read the guideTRT blood work and monitoring: diagnosis, follow-up, and questions for a telehealth clinic
Symptoms plus consistently low morning testosterone guide diagnosis. One result is not the whole story.
Read the guideReports
Data pages that the guides draw on: dated third-party ratings and records per provider, and the ranked price comparison per treatment. ElixaMD pricing is a price note for a program that is not in the directory.
- Ratings, complaints, and records by provider
- What people ask about Glutathione injection
- What people ask about NAD+ injection
- What people ask about NAD+ nasal spray
- What people ask about Oral semaglutide
- What people ask about Oral Sermorelin
- What people ask about Oral tirzepatide
- What people ask about Semaglutide
- What people ask about Sermorelin
- What people ask about Tirzepatide
- What people ask about Wegovy
- What people ask about Zepbound